Company / Net Debt per Share
RECURSION PHARMACEUTICALS, INC. Net Debt per Share History
FY2021-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$12.74
FY2021
5-year range
-$12.74 / -$12.74
FY2021-FY2021
Trend
-
vs FY2020
Sector context
#82 of 82
Health Care
What the data says
Among 82 Health Care companies, RECURSION PHARMACEUTICALS, INC. is in the top 0% for net debt per share.
Based on SEC 10-K filings.
-12.74 in FY2021.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 82This company -$12.74 Sector average $1.13
▼
-1227.6% below sector average
Company context
Key Data Points
- Altman Z-Score -0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -$12.74 | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026